Six readers
| reader | found | score |
|---|---|---|
| genetics Open Targets | no genetic evidence; overall 0.05 from other evidence | 0.00 |
| cell type Human Protein Atlas | expressed broadly, no clear home in brain cells | 0.40 |
| chemistry Open Targets | a small-molecule pocket | 0.60 |
| trials ClinicalTrials.gov | no Parkinson's trials on record: an open field | 1.00 |
| literature PubMed | 1 Parkinson's papers of 97 | 0.91 |
| pathways Reactome | 1 pathway; mostly mitochondrial quality control | 1.00 |
No case: the score is under the bar. Receipt 4881
Sealed predictions
- DECR1 in dopamine neurons, braak+0.85 (p 0.004) → +0.49 (p 0.177)receipt 4890
Swarm cases
receipt 4890: DECR1 in dopamine neurons, braak
- power
- full sample +0.60 (p 0.0083, n 18), 95% CI +0.19 to +0.83. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: +0.60 (p 0.0083, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.63 (p 0.0049, n 18). not the mix.
- skeptic
- leave-one-out range +0.55 to +0.73, sign flips 0; without severely affected donors +0.60 (p 0.0083, n 18). robust.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for DECR1 in dopamine neurons.
case closed: nothing better to follow up.
Receipts
loading the receipts